ZBiotics is a biotechnology research company headquartered in San Francisco, California. Known as the maker of the world's first genetically engineered probiotics, the company develops innovative functional health products.
Subscribe to see ZBiotics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ZBiotics is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $12M in August 2024. Xcout tracks 4 named people at ZBiotics, including Kat Townsend (Chief of Marketing).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ZBiotics's closest competitors — see the full list of competitors and alternatives →
Pendulum Therapeutics is a biotechnology company headquartered in San Francisco, California. Founded by scientific experts, it develops next-generation microbiome products and probiotic solutions to improve metabolic health.
Kopra Bio is a biotechnology company headquartered in San Francisco, California. The company specializes in genetically engineered virology solutions.
Probi researches, develops, and manufactures science-backed probiotic and biotic solutions for businesses operating in the dietary supplement, food and beverage, and pet care industries. The company provides customized probiotic strains, raw materials, and finished product manufacturing targeting various health areas such as digestive, immune, metabolic, and mental health.
Persephone Biosciences, Inc. is a synthetic biology company headquartered in San Diego, California. The company reimagines patient and infant health by developing clinically researched synbiotics derived from microbiome research.
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.